ECSP077182A - Metodos para el tratamiento de infecciones endobronquiales - Google Patents

Metodos para el tratamiento de infecciones endobronquiales

Info

Publication number
ECSP077182A
ECSP077182A EC2007007182A ECSP077182A ECSP077182A EC SP077182 A ECSP077182 A EC SP077182A EC 2007007182 A EC2007007182 A EC 2007007182A EC SP077182 A ECSP077182 A EC SP077182A EC SP077182 A ECSP077182 A EC SP077182A
Authority
EC
Ecuador
Prior art keywords
treatment
methods
endobronchial
endobronchial infections
patient
Prior art date
Application number
EC2007007182A
Other languages
English (en)
Inventor
Peter Challoner
Carlos Rodriguez
Thomas E Tarara
John D Lord
Original Assignee
Nektar Therapeutics
Novartis Vaccines & Diagnostic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics, Novartis Vaccines & Diagnostic Inc filed Critical Nektar Therapeutics
Publication of ECSP077182A publication Critical patent/ECSP077182A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención provee métodos para el tratamiento de una infección endobronquial en un paciente a través de la administración al sistema endobronquial del paciente de una composición en aerosol de polvo seco que comprende de 90 a 130 mg de un antibiótico de aminoglicósido de una a tres veces al día durante un primer período de tratamiento de 20 a 36 días.
EC2007007182A 2004-06-18 2007-01-18 Metodos para el tratamiento de infecciones endobronquiales ECSP077182A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58084804P 2004-06-18 2004-06-18

Publications (1)

Publication Number Publication Date
ECSP077182A true ECSP077182A (es) 2007-05-30

Family

ID=35782127

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2007007182A ECSP077182A (es) 2004-06-18 2007-01-18 Metodos para el tratamiento de infecciones endobronquiales

Country Status (25)

Country Link
US (3) US20080214481A1 (es)
EP (1) EP1765288B1 (es)
JP (3) JP2008503500A (es)
KR (2) KR20120131245A (es)
CN (1) CN101014320B (es)
AU (1) AU2005258078B2 (es)
BR (1) BRPI0512146A (es)
CA (1) CA2570976C (es)
DK (1) DK1765288T3 (es)
EC (1) ECSP077182A (es)
ES (1) ES2399279T3 (es)
HR (1) HRP20130076T1 (es)
IL (1) IL179873A (es)
MA (1) MA28740B1 (es)
MX (1) MXPA06014567A (es)
NO (1) NO338799B1 (es)
NZ (1) NZ552047A (es)
PL (1) PL1765288T3 (es)
PT (1) PT1765288E (es)
RU (1) RU2389477C2 (es)
SG (1) SG153833A1 (es)
SI (1) SI1765288T1 (es)
TN (1) TNSN06420A1 (es)
WO (1) WO2006002178A1 (es)
ZA (1) ZA200700420B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
USD914881S1 (en) 2003-11-05 2021-03-30 Abbott Diabetes Care Inc. Analyte sensor electronic mount
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US7883464B2 (en) 2005-09-30 2011-02-08 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
ES2666276T3 (es) * 2006-10-11 2018-05-03 Laboratoires Smb Sa Composición farmacéutica antiinfecciosa para inhalación
EP1938822A1 (en) * 2006-12-21 2008-07-02 Novartis AG Combination therapy for the treatment of airways disease
KR101621986B1 (ko) 2008-05-15 2016-05-17 노파르티스 아게 플루오로퀴놀론의 폐 전달
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
AU2010253770B9 (en) * 2009-05-29 2015-02-12 Pearl Therapeutics, Inc. Compositions for respiratory delivery of active agents and associated methods and systems
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
WO2011025549A1 (en) 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Medical devices and methods
CA2784207C (en) * 2009-12-14 2018-06-05 Chiesi Farmaceutici S.P.A. Antibiotic microparticles for inhalation
CA2766685A1 (en) 2010-03-24 2011-12-29 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
US11064921B2 (en) 2010-06-29 2021-07-20 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US9572774B2 (en) 2011-05-19 2017-02-21 Savara Inc. Dry powder vancomycin compositions and associated methods
US8826904B2 (en) 2011-07-12 2014-09-09 Cardeas Pharma Corporation Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
CA2841272C (en) 2011-07-12 2019-01-15 Alan Bruce Montgomery Formulations of amikacin and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (vap) and ventilator associated tracheal (vat) bronchitis
WO2013090215A2 (en) 2011-12-11 2013-06-20 Abbot Diabetes Care Inc. Analyte sensor devices, connections, and methods
WO2014055456A1 (en) * 2012-10-07 2014-04-10 Abbott Diabetes Care Inc. Medical device insertion indicators
CN102949379B (zh) * 2012-11-14 2014-11-05 中山大学 硫酸奈替米星吸入粉雾剂及其制备方法
US20140275517A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
AU2016260547B2 (en) 2015-05-14 2020-09-03 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
CN115444410B (zh) 2017-01-23 2025-08-15 雅培糖尿病护理公司 用于插入体内分析物传感器的施加器及组件
WO2020131159A1 (en) 2018-12-21 2020-06-25 Abbott Diabetes Care Inc. Systems, devices, and methods for analyte sensor insertion
WO2020163416A1 (en) * 2019-02-05 2020-08-13 Mylan Inc Devices and methods for tobramycin inhalation treatment
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
CN115942909A (zh) 2020-08-31 2023-04-07 雅培糖尿病护理公司 用于分析物传感器插入的系统、装置和方法
ES3000715T3 (en) 2020-09-15 2025-03-03 Abbott Diabetes Care Inc Device for analyte monitoring
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter
MY202051A (en) 2021-07-16 2024-03-30 Abbott Diabetes Care Inc Systems, devices, and methods for analyte monitoring

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
FR2224175B1 (es) 1973-04-04 1978-04-14 Isf Spa
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1017153B (it) 1974-07-15 1977-07-20 Isf Spa Apparecchio per inalazioni
SE438261B (sv) 1981-07-08 1985-04-15 Draco Ab Anvendning i dosinhalator av ett perforerat membran
GB8314308D0 (en) 1983-05-24 1983-06-29 Matburn Holdings Ltd Medical administration devices
SU1335297A1 (ru) * 1984-06-15 1987-09-07 Донецкий медицинский институт им.М.Горького Способ лечени больных хроническими заболевани ми легких
US4805811A (en) 1985-03-29 1989-02-21 Aktiebolaget Draco Dosage device
SE448277B (sv) 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
GB8909891D0 (en) 1989-04-28 1989-06-14 Riker Laboratories Inc Device
IT1243344B (it) 1990-07-16 1994-06-10 Promo Pack Sa Inalatore plurimonodose per medicamenti in polvere
WO1993000951A1 (en) 1991-07-02 1993-01-21 Inhale, Inc. Method and device for delivering aerosolized medicaments
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
US5388572A (en) 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
NZ285664A (en) 1994-05-18 1998-07-28 Inhale Therapeutic Syst Dry powder interferon composition adapted for pulmonary delivery
CN1318104C (zh) 1994-09-21 2007-05-30 耐科塔医药公司 送料管组件
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5508269A (en) * 1994-10-19 1996-04-16 Pathogenesis Corporation Aminoglycoside formulation for aerosolization
KR19980703876A (ko) 1995-04-14 1998-12-05 스티븐 엘. 허스트 분산성이 개선된 분말화된 약학적 조성물
US5826633A (en) 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
IL139231A0 (en) * 1998-05-27 2001-11-25 Euro Celtique Sa Preparations for the application of anti-inflammatory, especially antiseptic, agents and/or agents promoting the healing of wounds to the lower respiratory tract
BR9916296A (pt) * 1998-12-17 2004-06-29 Pathogenesis Corp Método para tratamento de bronquite crÈnica severa (bronquiectase) com um antibiótico em forma de aerossol
WO2001013891A2 (en) 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US6586008B1 (en) 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
US7442388B2 (en) 2000-05-10 2008-10-28 Weers Jeffry G Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
ATE322249T1 (de) 2001-05-18 2006-04-15 Chiron Corp System zur abgabe einer tobramycin-formulierung
DE10131917A1 (de) 2001-07-02 2003-01-23 Infineon Technologies Ag Verfahren zur Erzeugung einer stufenförmigen Struktur auf einem Substrat
US20030094173A1 (en) 2001-11-14 2003-05-22 Inhale Therapeutic Systems, Inc. Aerosolization device with improved endpiece connection
DK1443996T3 (da) 2001-11-14 2011-08-15 Novartis Ag Aerosoliseringsapparat indeholdende sammenkobleligt hoved- og endestykke
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
JP4739672B2 (ja) 2001-12-21 2011-08-03 ネクター セラピューティクス 湿気のバリアを有するカプセルパッケージ
JP2005530765A (ja) 2002-05-07 2005-10-13 ネクター セラピューティクス 乾燥粉末吸入器のためのカプセル及びそれを製造及び使用する方法
CN1493297A (zh) * 2003-09-13 2004-05-05 南昌弘益科技有限公司 妥布霉素吸入粉雾剂及其制备方法

Also Published As

Publication number Publication date
KR20070026604A (ko) 2007-03-08
US20120148641A1 (en) 2012-06-14
PT1765288E (pt) 2013-01-29
EP1765288A1 (en) 2007-03-28
NO20070253L (no) 2007-03-13
EP1765288B1 (en) 2012-11-07
BRPI0512146A (pt) 2008-02-12
TNSN06420A1 (en) 2008-02-22
JP2013056947A (ja) 2013-03-28
ES2399279T3 (es) 2013-03-27
CA2570976A1 (en) 2006-01-05
NO338799B1 (no) 2016-10-24
US20110097412A1 (en) 2011-04-28
CA2570976C (en) 2013-08-13
MXPA06014567A (es) 2007-07-24
JP2008503500A (ja) 2008-02-07
CN101014320B (zh) 2011-05-18
HRP20130076T1 (hr) 2013-03-31
PL1765288T3 (pl) 2013-04-30
KR20120131245A (ko) 2012-12-04
EP1765288A4 (en) 2009-05-13
AU2005258078B2 (en) 2010-09-30
DK1765288T3 (da) 2013-02-11
ZA200700420B (en) 2008-05-28
CN101014320A (zh) 2007-08-08
IL179873A0 (en) 2007-05-15
RU2007101906A (ru) 2008-07-27
NZ552047A (en) 2009-11-27
IL179873A (en) 2014-09-30
US8664187B2 (en) 2014-03-04
AU2005258078A1 (en) 2006-01-05
RU2389477C2 (ru) 2010-05-20
WO2006002178A1 (en) 2006-01-05
JP2012107047A (ja) 2012-06-07
SG153833A1 (en) 2009-07-29
SI1765288T1 (sl) 2013-02-28
MA28740B1 (fr) 2007-07-02
US20080214481A1 (en) 2008-09-04

Similar Documents

Publication Publication Date Title
SG153833A1 (en) Methods of treatment of endobronchial infections
ECSP099451A (es) Compuestos de urea policíclicos antibacterianos
NO20063105L (no) Anordning og fremgangsmate for administrering av terapeutiske midler
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
CU23367A3 (es) Formulación de moxifloxacino con sal común
DOP2020000058A (es) Compuestos monobactámicos cromanos para el tratamiento de infecciones bacterianas
UY31106A1 (es) Formulaciones que contienen triazinonas y hierro
CY1114363T1 (el) Ανθελμινθικος συνδυασμος
CL2007001427A1 (es) Sal de maleato de 5-amino-3-(2',3'-di-o-acetil-beta-d-ribofuranosil)-3h-tiazolo[4,5-d]pirimidin-2-ona; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de una infeccion po
UA94901C2 (ru) Антибактериальные производные пиперидина
NO20083250L (no) Antibakterielle pyrrolopyridiner, pyrrolopyrimidiner og pyrroloazepiner
CR8569A (es) Inhibidores de integrasa de vih
CL2009002129A1 (es) Derivados carboxiamida de lantibioticos; proceso de preparacion de dichos lantibioticos; composicion farmaceutica que lo contiene; utiles en el tratamiento de infecciones bacterianas.
TN2009000211A1 (en) Antiviral composition and method of use
ECSP045397A (es) 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS
BRPI0916885B8 (pt) composição farmacêutica
WO2005030109A3 (en) Regimen for the administration of rifamycin-class antibiotics
CL2007001910A1 (es) Compuestos derivados de penem; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
CR9991A (es) Nuevo derivado de pleuromutilina y su uso
UY28542A1 (es) Amidas macrocíclicas antibacterianas
AR064152A1 (es) Derivados de quinolina antibacterianos,composiciones farmaceuticas que los contienen y metodo de preparacion.
UY30629A1 (es) Nuevo péptido de actinomadura namibiensis
ECSP045405A (es) Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa
CR9691A (es) Inhibidores de 6-alquilideno-peneme b-lactama biciclicos y combinacion antibiotica de b-lactama: un antibiotico de amplio espectro
ATE311885T1 (de) Monobactam-antibakterielle verbindungen und anwendungsverfahren